About Thioredoxin domain-containing protein 15
Thioredoxin domain-containing protein 15 (TXNDC15) is a protein
from Homo sapiens identified by UniProt accession
Q96J42, 360 residues long.
MolForge cross-references it against 0 known binders and
42 disease associations.
Target properties
| Protein name | Thioredoxin domain-containing protein 15 |
| UniProt accession | Q96J42 |
| Gene | TXNDC15 |
| Organism | Homo sapiens |
| Length | 360 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (42)
Diseases linked to this target (Open Targets).
- Meckel syndrome · score 0.70
- meckel syndrome 14 · score 0.64
- Mungan syndrome · score 0.54
- neurodegenerative disease · score 0.31
- genetic disorder · score 0.19
- blood protein measurement · score 0.13
- severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive · score 0.12
- Menkes disease · score 0.03
- ovarian carcinoma · score 0.02
- visceral Leishmaniasis · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96J42-F1 | alphafold | PREDICTED | 64.22 | — |
Amino-acid sequence (360 residues)
MVPAAGRRPP RVMRLLGWWQ VLLWVLGLPV RGVEVAEESG RLWSEEQPAH PLQVGAVYLG EEELLHDPMG QDRAAEEANA VLGLDTQGDH MVMLSVIPGE AEDKVSSEPS GVTCGAGGAE DSRCNVRESL FSLDGAGAHF PDREEEYYTE PEVAESDAAP TEDSNNTESL KSPKVNCEER NITGLENFTL KILNMSQDLM DFLNPNGSDC TLVLFYTPWC RFSASLAPHF NSLPRAFPAL HFLALDASQH SSLSTRFGTV AVPNILLFQG AKPMARFNHT DRTLETLKIF IFNQTGIEAK KNVVVTQADQ IGPLPSTLIK SVDWLLVFSL FFLISFIMYA TIRTESIRWL IPGQEQEHVE
Explore Thioredoxin domain-containing protein 15 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets